TrianglePUBLICATIONS · 21252092
Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2011 Mar 17
- First author
- Jiang Q
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Jiang Q
- type
- Author
- name
- Xu LP
- type
- Author
- name
- Liu DH
- type
- Author
- name
- Liu KY
- type
- Author
- name
- Chen SS
- type
- Author
- name
- Jiang B
- type
- Author
- name
- Jiang H
- type
- Author
- name
- Chen H
- type
- Author
- name
- Chen YH
- type
- Author
- name
- Han W
- type
- Author
- name
- Zhang XH
- type
- Author
- name
- Wang Y
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Jiang Q
- type
- Author
- name
- Xu LP
- type
- Author
- name
- Liu DH
- type
- Author
- name
- Liu KY
- type
- Author
- name
- Chen SS
- type
- Author
- name
- Jiang B
- type
- Author
- name
- Jiang H
- type
- Author
- name
- Chen H
- type
- Author
- name
- Chen YH
- type
- Author
- name
- Han W
- type
- Author
- name
- Zhang XH
- type
- Author
- name
- Wang Y
- type
- Author
- bibliography ids
- nci-bib-34971078be5570c877d60a96
- book metadata
- content sha256
- b5ce68717deee9c66202f98bac1689154dbb3f159d8f632215593aef08f51701
- document type
- citation
- dois
- 10.1182/blood-2010-09-308510
- electronic publication date
- display
- 2011 Jan 20
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21252092
- immutable id
- pubmed:21252092@b5ce68717deee9c66202f98bac1689154dbb3f159d8f632215593aef08f51701
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 11
- name
- Blood
- nlm unique id
- 7603509
- pages
- 3032-40
- volume
- 117
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21252092
- provenance
- batch id
- edef4b7f1a2a505cd5a9
- provider
- NCBI PubMed ESummary
- record sha256
- fe0e0e0acd3ca0a9f55b542a0a348a49218b5ee5495e39c62cd02817046af2ef
- response sha256
- d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
- retrieved at
- 2026-09-09T23:46:38.027615+00:00
- publication date
- display
- 2011 Mar 17
- precision
- day
- year
- 2011
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase.
Preserved source evidence · Not medical advice